GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
13.15
-0.94 (-6.67%)
Mar 27, 2026, 4:00 PM EDT - Market closed
GH Research Market Cap
GH Research has a market cap or net worth of $815.69 million as of March 27, 2026. Its market cap has increased by 20.87% in one year.
Market Cap
815.69M
Enterprise Value
535.49M
1-Year Change
20.87%
Ranking
Category
Stock Price
$13.15
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $815.69M, an increase of 0.91%. That is a compound annual growth rate of 0.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 815.69M | 3.54% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | 808.33M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 848.05M |
| Arbutus Biopharma | 838.60M |
| Xencor | 837.53M |
| UroGen Pharma | 835.87M |
| Phathom Pharmaceuticals | 833.69M |
| MapLight Therapeutics | 820.61M |
| Janux Therapeutics | 801.76M |
| ARS Pharmaceuticals | 801.33M |